Matthew Doctor
CIK 1844838 · President and CEO · last filed 2024-11-26
Matthew Doctor is a President and CEO who has filed 17 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for RGS, was dated Oct 24, 2025. Current disclosed insider exposure totals $534.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$534.4K
1
17
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGS | President and CEO | 19,584 | $27.29 | $534.4K | $0 | 11 | 2024-11-26 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-24 | RGS | Notice (144) | −704 | -$21.5K | EDGAR |
| 2025-10-20 | RGS | Notice (144) | −745 | -$22.7K | EDGAR |
| 2025-10-15 | RGS | Notice (144) | −1,897 | -$58.0K | EDGAR |
| 2025-09-26 | RGS | Notice (144) | −437 | -$12.5K | EDGAR |
| 2025-09-19 | RGS | Notice (144) | −937 | -$26.7K | EDGAR |
| 2025-09-18 | RGS | Notice (144) | −9,626 | -$278.3K | EDGAR |
| 2024-11-26 | RGS | Grant (A) | +16,500 | $0 | EDGAR |
| 2024-11-19 | RGS | Tax (F) | −547 | -$12.8K | EDGAR |
| 2024-11-07 | RGS | Tax (F) | −339 | -$7.9K | EDGAR |
| 2024-02-09 | RGS | Tax (F) | −211 | -$2.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.